MENU
VRTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Vertex Pharmaceuticals (VRTX) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

VRTX is expected to report earnings to fall 7.31% to $4.06 per share on February 11

Vertex Pharmaceuticals VRTX Stock Earnings Reports
Q4'24
Est.
$4.06
Q3'24
Beat
by $0.30
Q2'24
Missed
by $1.13
Q1'24
Beat
by $0.68
Q4'23
Beat
by $0.13
The last earnings report on November 04 showed earnings per share of $4.38, beating the estimate of $4.08. With 718.75K shares outstanding, the current market capitalization sits at 124.63B.
View a ticker or compare two or three
VRTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company that discovers and develops novel, small molecule pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
50 Northern Avenue
Phone
+1 617 341-6100
Employees
5400
Web
https://www.vrtx.com